
NYSE:LDOS
This summary was created by AI, based on 7 opinions in the last 12 months.
Leidos (LDOS-N) has received a mixed set of reviews from experts. While some analysts express concerns regarding government pressure to lower costs and the potential overhang from their healthcare contracts, others see significant potential, especially amidst the current AI-fueled market dynamics. The company's management is noted for its strong performance, delivering consistent revenue beats over the past couple of years. Recent earnings reports illustrate a robust growth trajectory, with substantial year-over-year revenue increases and earnings per share that significantly surpassed market expectations. The consensus is generally optimistic, with frequent recommendations to adjust stop-loss levels to secure profits as the stock continues to perform well in the marketplace.
LDOS is a $20B market cap company providing scientific, engineering and technical services. The stock is up 36% YTD and 90% over one year. It trades at 16X earnings, with a 1.03% dividend. Historical growth has been very solid, and it generates good cash flow. The last quarter was excellent and EPS beat estimates by 35%. Estimates have also been moving up. There is a lot to like here for sure. Our main concern would be debt, at about 4X cash flow. But based on its growth and execution we would not see this as particularly problematic.
Unlock Premium - Try 5i Free
Leidos is a American stock, trading under the symbol LDOS (previously LDOS-N on Stockchase) on the New York Stock Exchange (LDOS). It is usually referred to as NYSE:LDOS or LDOS
In the last year, 8 stock analysts issued a Buy, Sell, or Hold rating on LDOS (previously LDOS-N on Stockchase). 7 analysts recommended to BUY and 1 analyst recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for Leidos.
Leidos was recommended as a Top Pick by Stephen Weiss, Founder, Short Hills Capital Partners on 2026-06-03. Read the latest stock experts ratings for Leidos.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Leidos.
Leidos is followed by 24 investors on Stockchase and is a trending stock that is worth watching.
On 2026-07-15, Leidos (LDOS) stock closed at a price of $108.21.
He sold it. It will stay at current levels. The big issue is the government is after all these consulting companies to lower their costs. Also, they have a big healthcare contract with the veteran hospitals, which is an overhang. Management is good, though.